These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 32464650)

  • 41. Practices in management of cancer treatment-related cardiovascular toxicity: A cardio-oncology survey.
    Jovenaux L; Cautela J; Resseguier N; Pibarot M; Taouqi M; Orabona M; Pinto J; Peyrol M; Barraud J; Laine M; Bonello L; Paganelli F; Barlesi F; Thuny F
    Int J Cardiol; 2017 Aug; 241():387-392. PubMed ID: 28365180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The European Association of Cardiovascular Imaging/Heart Failure Association Cardiac Oncology Toxicity Registry: long-term benefits for breast cancer treatment.
    Jerusalem G; Moonen M; Freres P; Lancellotti P
    Future Oncol; 2015; 11(20):2791-4. PubMed ID: 26344798
    [No Abstract]   [Full Text] [Related]  

  • 43. Brazilian cardio-oncology: the 10-year experience of the Instituto do Cancer do Estado de Sao Paulo.
    Costa IBSDS; Bittar CS; Fonseca SMR; E Silva CMPD; Dos Santos Rehder MHH; Rizk SI; Cruz CBBV; Figueiredo CS; de A Andrade FT; Barberino LA; de S Costa FA; Machado LP; González TB; Almeida MPC; Fukushima JT; Kalil Filho R; Hajjar LA
    BMC Cardiovasc Disord; 2020 Apr; 20(1):206. PubMed ID: 32345217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Promising Radiopharmaceutical Tracers for Detection of Cardiotoxicity in Cardio-oncology.
    Shaghaghi Z; Jalali Zefrei F; Salari A; Hojjati SA; Fakhr Mousavi SA; Farzipour S
    Curr Radiopharm; 2023 Jun; 16(3):171-184. PubMed ID: 36852813
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic Imaging in Cardio-oncology.
    Tong D; Zaha VG
    J Cardiovasc Transl Res; 2020 Jun; 13(3):357-366. PubMed ID: 31696405
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A cardio-oncology experience in Italy: results of a Tuscany regional-based survey.
    Canale ML; Camerini A; Magnacca M; Casolo G;
    J Cardiovasc Med (Hagerstown); 2014 Feb; 15(2):135-40. PubMed ID: 24553090
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Precision Cardio-Oncology.
    Dreyfuss AD; Bravo PE; Koumenis C; Ky B
    J Nucl Med; 2019 Apr; 60(4):443-450. PubMed ID: 30655328
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comprehensive diagnostic approach to cardiac events in cancer patients receiving antineoplastic therapy: A systematic review.
    Lafaras C; Kalafatis I; Lafara K; Koukoulitsa V; Mandala E
    Hell J Nucl Med; 2023; 26 Suppl():5-11. PubMed ID: 37658551
    [TBL] [Abstract][Full Text] [Related]  

  • 49. State-of-the-art modalities in cardio-oncology: insight from a nuclear medicine approach.
    Jokar N; Amini A; Ravanbod M; Barekat M; Shooli H; Gholamrezanezhad A; Assadi M
    Nucl Med Rev Cent East Eur; 2021; 24(2):82-92. PubMed ID: 34382672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations.
    Curigliano G; Lenihan D; Fradley M; Ganatra S; Barac A; Blaes A; Herrmann J; Porter C; Lyon AR; Lancellotti P; Patel A; DeCara J; Mitchell J; Harrison E; Moslehi J; Witteles R; Calabro MG; Orecchia R; de Azambuja E; Zamorano JL; Krone R; Iakobishvili Z; Carver J; Armenian S; Ky B; Cardinale D; Cipolla CM; Dent S; Jordan K;
    Ann Oncol; 2020 Feb; 31(2):171-190. PubMed ID: 31959335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Focused echocardiography in cardio-oncology.
    Keramida K; Farmakis D; López Fernández T; Lancellotti P
    Echocardiography; 2020 Aug; 37(8):1149-1158. PubMed ID: 33295662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology.
    Abdelgawad IY; Grant MKO; Zordoky BN
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30875799
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardio-oncology: the Nuclear Option.
    Alvarez JA; Russell RR
    Curr Cardiol Rep; 2017 Apr; 19(4):31. PubMed ID: 28315122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardio-Oncology: A New Clinical Frontier and Novel Platform for Cardiovascular Investigation.
    Moslehi JJ
    Circulation; 2024 Aug; 150(7):513-515. PubMed ID: 39133773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of serum biomarkers in cancer patients receiving cardiotoxic cancer therapies: a position statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology.
    Pudil R; Mueller C; Čelutkienė J; Henriksen PA; Lenihan D; Dent S; Barac A; Stanway S; Moslehi J; Suter TM; Ky B; Štěrba M; Cardinale D; Cohen-Solal A; Tocchetti CG; Farmakis D; Bergler-Klein J; Anker MS; Von Haehling S; Belenkov Y; Iakobishvili Z; Maack C; Ciardiello F; Ruschitzka F; Coats AJS; Seferovic P; Lainscak M; Piepoli MF; Chioncel O; Bax J; Hulot JS; Skouri H; Hägler-Laube ES; Asteggiano R; Fernandez TL; de Boer RA; Lyon AR
    Eur J Heart Fail; 2020 Nov; 22(11):1966-1983. PubMed ID: 33006257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardio-oncology: Clinical and imaging perspectives for optimal cardiodetection and cardioprotection in patients with cancer.
    Thuny F; Huttin O; Ederhy S
    Arch Cardiovasc Dis; 2019 Oct; 112(10):550-558. PubMed ID: 31522992
    [No Abstract]   [Full Text] [Related]  

  • 57. The evaluation of aortic stenosis, how the new guidelines are implemented across Europe: a survey by EACVI.
    Michalski B; Dweck MR; Marsan NA; Cameli M; D'Andrea A; Carvalho RF; Holte E; Podlesnikar T; Manka R; Haugaa KH
    Eur Heart J Cardiovasc Imaging; 2020 Apr; 21(4):357-362. PubMed ID: 32196100
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Role of Imaging with Cardiac Computed Tomography in Cardio-Oncology Patients.
    Pitekova B; Ravi S; Shah SV; Mladosievicova B; Heitner S; Ferencik M
    Curr Cardiol Rep; 2016 Sep; 18(9):87. PubMed ID: 27443383
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment I. Oncology.
    Yeh ETH; Ewer MS; Moslehi J; Dlugosz-Danecka M; Banchs J; Chang HM; Minotti G
    Semin Oncol; 2019 Dec; 46(6):397-402. PubMed ID: 31753424
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiovascular Toxicities in Pediatric Cancer Survivors.
    Ryan TD; Nagarajan R; Godown J
    Cardiol Clin; 2019 Nov; 37(4):533-544. PubMed ID: 31587793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.